Cbd Pathway

The CBD Pathway refers to cannabis genetics selected or bred for elevated cannabidiol (CBD) production relative to THC. These lineages arise from naturally occurring high-CBD phenotypes, often stabilized through selective breeding or discovered in hemp-type cannabis populations. Breeders working in this category typically employ marker-assisted selection or traditional phenotype screening to isolate and maintain CBD-dominant traits across generations. CBD Pathway strains are commonly associated with hemp breeding programs and therapeutic-oriented cultivar development, though cannabinoid ratios vary widely depending on parental genetics and cultivation conditions. Understanding CBD inheritance patterns has become central to modern cannabis breeding, as different chemotypes can emerge from the same genetic cross depending on environmental factors and epigenetic expression.

Breeders use CBD Pathway genetics as foundational stock for developing cultivars with specific cannabinoid profiles, including 1:1 THC:CBD ratios, pure CBD-dominant lines, and minor-cannabinoid-enriched varieties. Backcrossing programs frequently incorporate known CBD-producing parents to stabilize this trait while introducing desired agronomic or flavor characteristics from other lineages.